CVS Health Jumps On Q4 Earnings Beat
Q4 2024 Management View CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, ...
Sees FY25 free cash flow $6.5B. The company said, “The Company issued its full-year 2025 GAAP diluted EPS guidance range of $4.58 to $4.83 and ...
CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...
CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...
Reports Q4 revenue $97.7B, consensus $96.88B. The company said, “Our integrated model allows us to uniquely deliver a simpler, connected ...
Adjusted EPS of $1.19 decreased from $2.12 in the prior year, beating the consensus of $0.93, primarily due to a decline in ...
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...
U.S. stock futures are little changed as investors watch for January inflation data, and Fed Chair Jerome Powell is set to ...
CVS Group plc (LON:CVSG) shareholders should be happy to see the share price up 20% in the last month. But that doesn't change the fact that the returns over the last three years have been less than ...
Hosted on MSN1d
CVS Showered With Upgrades, PT Hikes After Q4 Beat Powers Stock To Best Day In Over 25 Years: Retail Cheer GrowsShares of CVS Health Corp. continued climbing premarket Thursday after a blockbuster session driven by stronger-than-expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback